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T 
he prevalence and severity of allergic diseases, in par- 
ticular those  affecting the  respiratory system,  are  in- 
creasing at an alarming rate in the developed countries, and 
the  international  research  effort  into  the  etiology  and 
pathogenesis  of these  syndromes  is  rapidly  expanding  to 
meet  this  challenge.  The  immunoinflammatory reactions 
that mediate airway tissue  damage in allergic (atopic) sub- 
jects stem from aberrant T  cell responses to a range of air- 
borne  environmental antigens  that  seemingly are ignored 
by non-atopic individuals. At the T  cell level, allergic reac- 
tivity manifests as production of a Th-2-1ike cytokine pro- 
file at each challenge  (1,  2),  and mounting evidence (re- 
viewed briefly below) suggests that the development of this 
pattern of T  cell  sensitization is frequently associated with 
exposure to high levels of the relevant antigens during early 
infancy. 
This finding contrasts with the traditional experimental 
literature, in which parenteral antigenic challenge of neo- 
natal animals leads  preferentially to tolerance induction, a 
process most commonly ascribed to T  cell anergy and/or 
deletion (3-5). However in this issue of the journal, Singh 
et al. (6) present the results of a comprehensive study from 
a murine model, which focuses on the pattern of underly- 
ing antigen-specific T  cell cytokine responses  during the 
induction  and  subsequent  expression of classical  neonatal 
tolerance. They demonstrate  that  neonatal antigen  expo- 
sure triggers an initially heterogeneous T  cell response con- 
taining both Th-1- and Th-2-like elements, which results 
not  in  eventual  T  cell  deletion/anergy  but  instead  in 
"priming" for subsequent immune deviation toward a pat- 
tern ofT cell immunity that is skewed toward Th-2. Their 
discussion of the relevance of this neonatal tolerance model 
is  couched specifically in  terms  of autoimmune  diseases. 
However, as argued below, the underlying T  cell selection 
process is equally relevant to the etiology of human allergic 
diseases. 
Protection against Allergic Sensitization: 
Exclusion versus Regulation 
Until  comparatively recently, expression of the  allergic 
responder phenotype in  humans  was  held  to  result from 
failure of a  series  of active and passive  exclusion mecha- 
nisms,  operative at mucosal surfaces,  which limits  contact 
between inert environmental antigens such as pollen pro- 
teins (potential allergens)  and the T  cell system. Identifica- 
tion of secretory IgA deficiency as a predisposing factor to- 
ward development of allergic disease (7) served to reinforce 
this general view. 
However, parallel findings in the mucosal immunology 
literature  have  increasingly  cast  doubt  on  this  simplistic 
model. In particular, the results of studies of the phenome- 
non of oral tolerance (8) and its respiratory tract equivalent 
(9) argued that protection against  the development of im- 
mediate  and  delayed hypersensitivity to  ingested  and  in- 
haled allergens depended on a series  of cognate immuno- 
logical processes,  the  triggering  of which  (by  definition) 
required the passage  of sufficient allergen across  epithelial 
barriers to effectively engage the T  cell system. 
The nature  of the  regulatory mechanism(s)  underlying 
these latter processes is the subject of ongoing, intense de- 
bate.  Oral tolerance has  been variously ascribed to active 
suppression  mediated by regulatory T  cells  (10,  11),  the 
leakage  into  blood  of tolerogenic low  molecular weight 
peptides derived from protein antigens digested in the gut 
(12),  or induction of specific T  cell anergy (13). This con- 
troversy has been resolved partly by the finding that differ- 
ent  mechanisms  operated at  the  extremes of the  allergen 
dose  response curve, viz.,  repeated low  dose feeding in- 
duces regulatory T  cells  that  mediate  immune  deviation, 
whereas progressively higher allergen doses induce T  cell 
anergy (14,  15)  or eventually T  cell deletion (16).  How- 
ever, the  mechanism(s)  underlying this particular form of 
immune deviation remains unclear. 
Repeated exposure of rodents to aerosols containing low 
levels of allergen also induces long-lasting tolerance, which 
is now recognized as immune deviation (17). This results in 
selective suppression of both IgE and delayed type hyper- 
sensitivity  (DTH)  responses,  with  concomitant preserva- 
tion  of IgG2~/2b production  (9,  18).  CD8 +  regulatory T 
cells,  in  particular  a  subset  of apparently  antigen-specific 
CD8 + T  ~//~  cells (18), play an important role in this pro- 
cess. An additional finding from these studies was that the 
initial activation of these CD8 + regulatory T  cells was ab- 
solutely dependent on an  initial short-lived burst  of help 
from  CD4 +  Th-2  cells  responding  to  the  same  antigen 
(17),  and  the  presence  of the  latter  cells  in  the  regional 
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mals  was  associated with a transient phase  of specific IgE 
production (17). Moreover, this finding echoes the original 
report describing oral tolerance (19),  in which guinea pigs 
placed on a diet a supplemented with OVA developed se- 
vere but transient (IgE-mediated) food allergy to OVA, be- 
fore the eventual onset of  protective tolerance. 
Etiology of Allergic Disease in Humans: 
Significance of Neonatal Allergen Exposure 
By far the most common allergies  in humans are those 
induced  by  airborne  antigens,  which  suggests  that  the 
mechanism(s) that normally protects against  allergic sensiti- 
zation at mucosal surfaces  operates at a lower level of effi- 
ciency in the respiratory tract than, for example, in the gut 
(20).  The fact that  these latter mechanisms  are  predomi- 
nantly antigen-specific and based on a form (or forms) of 
immune deviation can be deduced from three lines of evi- 
dence: (a) the precursor frequency ofT cells reactive to the 
major inhalant allergens is comparable in the blood of aller- 
gic and nonallergic subjects (21);  (b) sensitive short-term T 
cell activation assays demonstrate specific reactivity to in- 
halant allergens in nearly 100% of blood samples from both 
allergic  and  normal  subjects  (22,  23);  and  (c)  cytokine- 
secreting T  cell clones reactive to inhalant allergens can be 
readily propagated  from bulk  cultures  of allergen-stimu- 
lated blood cells from both normals and atopics (1, 2). Fur- 
thermore, consistent with what has been learned from the 
study of IgE switch regulation in  the  murine system, the 
cytokine profiles of allergen-specific T  cell clones isolated 
from atopics are skewed toward a Th-2-1ike (or in some 
cases, Th-0-1ike) profile, compared with a TH-l-like pro- 
file in non-atopics (l, 2). 
Our understanding of the etiology of allergic disease ac- 
cordingly turns on the question of how the T  cell system is 
primed  and locked into  one  of these  mutually exclusive 
patterns of reactivity. In the animals studies, it is clear that 
antigen-driven  selection  for  long-term  Th-l-like  versus 
Th-2-1ike memory against  individual inhaled antigens oc- 
curs over the course of the first  few exposures and,  once 
consolidated, is not readily reversible (9, 20). With respect 
to exposure of humans to airborne allergens that are ubiq- 
uitous in the natural environment, the corresponding pe- 
riod of initial exposure of the immunologically naive im- 
mune  system generally occurs during late  fetal and  early 
postnatal life. 
The  first  indication  that  antigen-driven  immune  re- 
sponses occuring during very early life could influence the 
expression of the allergic phenotype in adulthood was pro- 
vided in  a  series  of independent studies,  performed with 
children  and  young adults,  that  demonstrated  that  being 
born during the pollen season was associated with a signifi- 
candy increased risk  of developing pollen allergy in later 
life (reviewed in reference 24). In this context, the capacity 
to develop oral tolerance and its respiratory tract equivalent 
is  poorly developed at birth  in  experimental animals  and 
does not reach adult-equivalent levels of competence until 
approximately the time of weaning (25,  26). It is tempting 
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to speculate that similar developmental deficiencies in im- 
mune function in human infants may underlie their height- 
ened susceptibility to allergic sensitization against mucosally 
presented antigens. 
An indirect window into the effects of allergen exposure 
during this  key period on underlying T  cell immunity is 
provided  via  a  series  of prospective  seroepidemiological 
studies that have tracked allergen-specific antibody titers in 
individual  subjects  from  birth  through  early  childhood. 
These  studies  have  uncovered  an  intriguing  pattern  of 
change in the type and magnitude of allergen-specific anti- 
body responses at different ages. Thus, virtually all children 
initiate IgG1 production against  both inhalant and food al- 
lergens by 3 mo of age  (27-29);  this production typically 
(especially in relation to food allergens)  peaks in affinity and 
titer during infancy and wanes thereafter (29), whereas cor- 
responding IgG  4 responses  continue to  develop  (28,  29). 
The intrinsic  biphasic  nature  of the  immune  response to 
environmental  allergens  in  most  children  is  even  more 
marked when individual IgE titers are tracked: after infants 
are introduced to solid foods, typically they develop vary- 
ing levels of IgE antibodies against  one or more common 
food antigens,  such as  egg,  cow's milk,  etc.; titers usually 
peak in infants at ~9 mo of age and rapidly wane thereafter 
(30). Corresponding low-level IgE responses to inhalant al- 
lergens develop more slowly, presumably because inhalant 
antigens produce much lower overall levels of stimulation 
in comparison with dietary allergens, but nevertheless they 
are detectable in virtually all children by the age of 2-3 yr 
(20,  30).  However,  as  is  the  case  with  dietary allergens, 
these responses usually wane, but they do so comparatively 
slowly and  often  do  not  disappear  until  ~5-6  yr of age 
(20, 30). 
This early pattern of transient Th-2-dependent antibody 
production against  nonpathogenic environmental antigens 
appears common to all children and may represent the de- 
fault response to mucosal challenge; this finding is also con- 
sistent with the result of in vitro studies demonstrating that 
naive neonatal CD4 + human T  cells produce IL-4 at prim- 
ing  (31).  Moreover, as noted above, it mirrors the initial 
Th-2  skewing  of the  response  of immunologically naive 
experimental animals  to  "new" ingested  or inhaled anti- 
gens, during the early phase of tolerance induction. 
In the case of responses to dietary allergens, the regula- 
tory process leading to the termination of antigen-specific 
IgE  production  is  clearly  very  effective,  given  the  ex- 
tremely low prevalence of  food allergy in the adult popula- 
tion. However, a steadily increasing percentage of the pop- 
ulation is displaying hypersensitivity to one or more airborne 
environmental allergens,  which  manifest as  IgE  responses 
that fail to terminate during childhood and instead persist 
into adulthood (failure  to develop tolerance?) or reappear 
in adulthood (loss of tolerance?). 
Development of T Cell Immunity to Environmental 
Allergens in Humans:  The Emerging Picture 
In  contrast to  the  relatively broad serological literature 
on the postnatal development of  immunity to environmen- tal allergens in humans, direct studies on the nature of the 
underlying T  cell responses have been begun only recently. 
The most productive approach has involved prospective 
studies on peripheral blood T  cell reactivity to panels of al- 
lergens  in  cohorts  of infants,  bled  at  strategic  intervals 
throughout  early childhood.  Analyses  of the  relevant re- 
sponse  patterns  have  thus  far  relied  exclusively on  lym- 
phoproliferation  assays, because  the  low  percursor  fre- 
quency of allergen-specific T  cells in these early responses 
militates against  the use of conventional cytokine assays. 
It is becoming clear from these studies that major differ- 
ences exist between the patterns oft  cell reactivity to food 
and to inhalant allergens, as predicted by the available data 
on respective antibody titers during childhood (24).  Nota- 
bly,  lymphoproliferative responses  to  the  major  inhalant 
allergens increase markedly in frequency and intensity be- 
tween  infancy and  adulthood,  in  contrast  to  parallel  re- 
sponses to food allergens, which peak in early infancy and 
decline thereafter (22,  32).  These disparate  patterns  have 
been  suggested  to  reflect the  relative importance  of im- 
mune deviation versus T  cell deletion mechanisms  at the 
two challenge sites,  triggered respectively by repeated ex- 
posure  to  nanogram  levels  of inhaled versus  microgram- 
to-gram levels of ingested allergens (20, 32). 
Elucidation  of relevant  T-cell  cytokine  response  pat- 
terns,  particularly  during  the  perinatal  period,  represents 
the major priority for future research in this area.  The re- 
suits of prehminary studies on cytokine levels in the blood 
of infants have detected a transient rise in IL-4 concentra- 
tions  during early infancy (33,  34),  which coincides with 
the transient peak of food allergen-specific IgE titers that 
commonly occurs during the first  year of life (30).  How- 
ever, the key information still lacking relates to the cyto- 
kine phenotype of allergen-specific T  helper cells  during 
the  initial  phase  of these  immune  responses;  studies  em- 
ploying semi-quantitative reverse transcriptase-PCR tech- 
nology to address  this important question are in progress at 
several centers. 
When and How Is T Cell Priming to Environmental Allergens 
Initiated?  These questions have not been answered defini- 
tively, but some tantalizing clues are available.  It is evident 
that in many cases,  initial priming of the T  cell system is 
initiated in utero. This conclusion follows from the rash of 
recent reports  (e.g.,  references 32,  35-37)  demonstrating 
that lymphoproliferative responses  of cord blood cells  to 
food and  inhalant  allergens  are  common in  infants  both 
with/without atopic family history. 
However, whereas responses to ubiquitous environmen- 
tal allergens are common in cord blood, parallel responses 
to vaccine antigens such as tetanus toxoid, to which preg- 
nant women are not generally exposed are not found (32). 
This  suggests  that  transplacentally  transferred  allergen  or 
processed peptides derived from the latter, perhaps in con- 
junction  with  maternally derived  IgG-subclass  antibodies 
which  are present in  virtually all neonatal blood samples 
(27),  may  provide  the  initial  trigger(s).  In  this  context, 
there are several precedents in the literature for induction 
of tolerance/immune deviation in neonatal animals  associ- 
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ated with transplacental transfer of either specific antibodies 
(38) or dietary antigens (39). 
Does Perinatal Priming to Environmental Allergens Contribute 
to the Maintenance of Immunological Homeostasis or Does It Pre- 
dispose to the Development of  Allergic Disease?  As argued above, 
it seems unlikely that perinatal priming per se constitutes a 
risk factor, given that it appears universal. Instead, it may be 
part of a normal education process in which the immature 
immune system is primed for the subsequent selection of 
host protective immunity (in this case,  Th-l-like),  under 
drive  from  environmental  allergens  that  are  encountered 
during subsequent childhood. 
The accompanying paper by Singh  et  al.  (6)  illustrates 
the other side of this coin, viz., how neonatal T  cell prim- 
ing that elicits an initially heterogeneous response can con- 
versely set triggers for later immune deviation toward Th-2- 
like  immunity.  Their discussion  emphasizes the  potential 
importance of such a mechanism in  silencing autoaggres- 
sive T  cell responses. Analogous to the situation outlined 
above for allergen reactive T  cells, human cord blood also 
contains surprisingly high numbers of T  cells responsive to 
such autoantigens as acetylcholine receptor and myelin ba- 
sic  protein, which moreover display a mixed Th-1/Th-2 
cytokine pattern (40). 
Why Should Perinatal T  Cell Priming Preferentially Lead to 
Immune Deviation toward Th-1 Responses against One Class of 
Antigen (Environmental Allergens) and to Th-2 Responses against 
Another (Self  Antigens)?  This  question  remains  to  be  de- 
termined, but the answer is likely to center around differ- 
ences in the respective modes of antigen presentation to the 
immune system, both at initial priming and during the en- 
suing antigen-driven T  cell selection process. 
In relation to responses to airborne environmental aller- 
gens, recent studies using adult experimental animals  have 
demonstrated the central role of a network of intraepithe- 
lial dendritic cells (DC), the majority of which express high 
levels of class II major histocompatibility complex (MHC) 
in the delivery of inhaled antigens from the airway mucosa 
to  the  T  cell system (41).  However, in neonatal animals, 
this DC population is predominantly MHC class II low or 
negative, and they do not develop adult-equivalent patterns 
of MHC class II expression, or reach comparable densities 
with the epithelium, until the time of weaning (42).  The 
nature of antigenic signaling to the T  cell system in neona- 
tal animals via the airway epithelial DC network is there- 
fore  likely  to  differ both  qualitatively  and  quantitatively 
from that in adults.  It has not yet been formally established 
that a comparable DC developmental pattern occurs in the 
airway epithelium of humans during infancy, but the close 
similarities  between respective networks  in  adult  humans 
and  mature  experimental  animals  from  several  different 
species  (references  41  and  43)  suggest  that  the  latter  is 
likely. If so, we can speculate that the kinetics of postnatal 
maturation of the airway DC network may be one of the 
key factors in the immune deviation processes that deter- 
mine the nature of the long-term T  cell memory for envi- 
ronmental allergens. The author's laboratory is supported by the National Health and Medical Research Council of Australia and 
Glaxo Wellcome. 
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